Impact of pre-treatment variables on the completion of

Autor:	V, Lavelli, A G, Nappi, P, Caputo, A N, Asabella, M, Fanelli, A, Sardaro, C, Altini, C, Ferrari, Giuseppe, Rubini
Rok vydání:	2019
Předmět:	Aged 80 and over Male Radioisotopes Bone Neoplasms Middle Aged Prostate-Specific Antigen Alkaline Phosphatase Tumor Burden Hemoglobins Prostatic Neoplasms Castration-Resistant Treatment Outcome Humans Neoplasm Metastasis Radiopharmaceuticals Aged Radium
Zdroj:	Hellenic journal of nuclear medicine. 22
ISSN:	1790-5427
Popis:	Radium-223 dichloride (30 consecutive mCRPC patients (mean age 77 years old), who were admitted for Ra223-therapy at our Department from February 2016 to October 2018, were enrolled for the analysis. The population was grouped as patients who completed16/30 (53%) patients wereOur preliminary analysis demonstrates that the high tumor burden represents the most important pre-treatment factor that could affect treatment completion and that needs to be considered before starting
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::256012f2355da7148c5002ddef8acf06 https://pubmed.ncbi.nlm.nih.gov/31802056 Zobrazit plný text záznamu